GALNT3 Inhibits the Progression of Cerebral Ischemia–Reperfusion Injury by Stabilizing TREM2 via O‐ GalNAc Glycosylation
CNS Neuroscience & Therapeutics · 2026-03 · 32 (3)
DOI: 10.1002/cns.70828 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 11.03.2026. Verfasst von Xinyi Fei und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China. Hauptthemen laut MEDLINE: N-Acetylgalactosaminyltransferases, Reperfusion Injury, Membrane Glycoproteins, Receptors, Immunologic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and Objective Cerebral ischemia–reperfusion injury (CIRI) is a major cause of poor outcome after ischemic stroke, and effective therapeutic targets are lacking. This study aimed to investigate the role of polypeptide N‐acetylgalactosaminyltransferase 3 (GALNT3) in CIRI.
Methods
The mouse transient middle cerebral artery occlusion/reperfusion (tMCAO/R) model was established, and transcriptomic analysis of the peri‐infarct cortex was performed to screen target genes. In vivo experiments, neurological scoring and TTC staining were used to assess the effects of GALNT3 on brain injury. In vitro, microglial HMC3 cells subjected to oxygen–glucose deprivation/reoxygenation (OGD/R) were used to model CIRI and further analyze the effects of GALNT3 on macrophage polarization and inflammatory factor expression.
Results
Transcriptomic analysis of the peri‐infarct cortex in the tMCAO/R model identified GALNT3 as a significantly down‐regulated gene. GALNT3 overexpression reduced infarct volume, improved neurological function, and suppressed neuronal apoptosis, oxidative stress, and neuroinflammation in tMCAO/R mice. Subsequently, GALNT3 was further demonstrated to inhibit microglial M1 polarization and down‐regulate inflammatory factors in the OGD/R model. Further mechanism investigation revealed that GALNT3, acting as a mucin type O glycosylation initiating enzyme, directly interacted with triggering receptor expressed on myeloid cells 2 (TREM2) and promoted its O GalNAc glycosylation, predominantly at serine 147, thereby enhancing TREM2 protein stability. TREM2 knockdown stimulated inflammatory responses that were inhibited by GALNT3 overexpression in OGD/R‐treated microglia.
Conclusion
This study revealed a novel GALNT3/TREM2 regulatory axis that restricts neuroinflammation and injury after CIRI, highlighting GALNT3‐mediated O‐glycosylation as a potential therapeutic strategy for CIRI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
- Department of Hepatobiliary and Pancreatic Surgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
ORCID-Profile: Shan Yu
Zitieren
APA
Fei, X., Yang, J., Zhang, R., Zhang, Y., & Yu, S. (2026). GALNT3 Inhibits the Progression of Cerebral Ischemia–Reperfusion Injury by Stabilizing TREM2 via O‐ GalNAc Glycosylation. CNS Neuroscience & Therapeutics, 32(3). https://doi.org/10.1002/cns.70828
Vancouver
Fei X, Yang J, Zhang R, Zhang Y, Yu S. GALNT3 Inhibits the Progression of Cerebral Ischemia–Reperfusion Injury by Stabilizing TREM2 via O‐ GalNAc Glycosylation. CNS Neuroscience & Therapeutics. 2026;32(3). doi:10.1002/cns.70828
BibTeX
@article{Fei2026,
author = {Fei, Xinyi and Yang, Jinghui and Zhang, Rui and Zhang, Yu and Yu, Shan},
title = {GALNT3 Inhibits the Progression of Cerebral Ischemia–Reperfusion Injury by Stabilizing TREM2 via O‐ GalNAc Glycosylation},
journal = {CNS Neuroscience & Therapeutics},
year = {2026},
volume = {32},
number = {3},
doi = {10.1002/cns.70828}
}
EUVIMED